LaSonji A. Holman

4.7k total citations
6 papers, 301 citations indexed

About

LaSonji A. Holman is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, LaSonji A. Holman has authored 6 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in LaSonji A. Holman's work include Hepatitis B Virus Studies (2 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). LaSonji A. Holman is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Influenza Virus Research Studies (2 papers) and Respiratory viral infections research (2 papers). LaSonji A. Holman collaborates with scholars based in United States, Netherlands and Serbia. LaSonji A. Holman's co-authors include Barney S. Graham, Richard A. Koup, Julie E. Ledgerwood, Galina V. Yamshchikov, Pamela Costner, John R. Mascola, Mary E. Enama, Robert T. Bailer, Gary J. Nabel and Mario Roederer and has published in prestigious journals such as PLoS ONE, Vaccine and Human Vaccines & Immunotherapeutics.

In The Last Decade

LaSonji A. Holman

6 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
LaSonji A. Holman United States	6	138	123	64	61	51	6	301
Pamela Costner United States	6	125 0.9×	112 0.9×	64 1.0×	51 0.8×	46 0.9×	6	305
Alberto Spanò Italy	13	110 0.8×	188 1.5×	29 0.5×	44 0.7×	17 0.3×	18	373
Jérôme Jacques France	12	228 1.7×	213 1.7×	26 0.4×	56 0.9×	19 0.4×	17	418
Vidisha Singh United States	12	198 1.4×	144 1.2×	44 0.7×	59 1.0×	31 0.6×	16	357
Sonia Caracciolo Italy	7	101 0.7×	128 1.0×	27 0.4×	52 0.9×	21 0.4×	8	287
Varun C. Anipindi Canada	10	66 0.5×	112 0.9×	35 0.5×	232 3.8×	29 0.6×	13	460
P. C. Belitsos United States	6	184 1.3×	126 1.0×	80 1.3×	50 0.8×	9 0.2×	6	460
Matthew L. Boisen United States	13	378 2.7×	136 1.1×	23 0.4×	56 0.9×	33 0.6×	16	483
Christine C. Roberts United States	11	81 0.6×	249 2.0×	81 1.3×	61 1.0×	21 0.4×	23	404
Georgina Bowyer United Kingdom	12	139 1.0×	91 0.7×	21 0.3×	207 3.4×	29 0.6×	21	409

Countries citing papers authored by LaSonji A. Holman

Since Specialization

Citations

This map shows the geographic impact of LaSonji A. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LaSonji A. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LaSonji A. Holman more than expected).

Fields of papers citing papers by LaSonji A. Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LaSonji A. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LaSonji A. Holman. The network helps show where LaSonji A. Holman may publish in the future.

Co-authorship network of co-authors of LaSonji A. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of LaSonji A. Holman. A scholar is included among the top collaborators of LaSonji A. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LaSonji A. Holman. LaSonji A. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Coates, Emily E., Pamela Costner, Martha Nason, et al.. (2017). Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses. Clinical Nuclear Medicine. 42(5). 329–334. 57 indexed citations

2.

Ledgerwood, Julie E., Zonghui Hu, Pamela Costner, et al.. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary Clinical Trials. 44. 112–118. 11 indexed citations

3.

Crank, Michelle C., Ingelise J. Gordon, Galina V. Yamshchikov, et al.. (2015). Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults. PLoS ONE. 10(4). e0123969–e0123969. 20 indexed citations

4.

Enama, Mary E., Julie E. Ledgerwood, Laura Novik, et al.. (2014). Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011). PLoS ONE. 9(3). e91366–e91366. 22 indexed citations

5.

Coates, Emily E., Pamela Costner, Troy J. Kemp, et al.. (2014). Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus. Human Vaccines & Immunotherapeutics. 10(12). 3446–3454. 50 indexed citations

6.

Ledgerwood, Julie E., Pamela Costner, Niraj M. Desai, et al.. (2010). A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 29(2). 304–313. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact